Biopharmaceutical Contract Manufacturing Organization (CMO) Global Market Opportunities And Strategies To 2033
Including: 1) By Product: Biologics; Biosimilars2) By Source: Mammalian; Non-Mammalian3) By Service: Manufacturing; Fill And Finish Operations; Analytical And QC (Quality Check) Studies And PackagingCovering: Catalent Inc.; Cytiva; Rentschler Biopharma; Boehringer Ingelheim GmbH; AGC Biologics Inc.
Biopharmaceutical Contract Manufacturing Organization (CMO) Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global biopharmaceutical contract manufacturing organization (CMO) market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description:
Where is the largest and fastest-growing market for biopharmaceutical contract manufacturing organization (CMO)? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The biopharmaceutical contract manufacturing organization (CMO) market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider biopharmaceutical contract manufacturing organization (CMO) market; and compares it with other markets.
The report covers the following chapters
Introduction And Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by source and by service.
Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario - The report provides an analysis of the impact of the Russia-Ukraine war, impact of the COVID-19 pandemic and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the biopharmaceutical contract manufacturing organization (CMO) market.
Global Market Size and Growth - Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by source and by service in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size And Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies - Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
Competitive Dashboard - Briefs on competitive dashboard of major players.
Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations - This section includes recommendations for biopharmaceutical contract manufacturing organization (CMO) providers in terms of product/service offerings geographic expansion, marketing strategies and target groups..
Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered:
1) By Product: Biologics; Biosimilars
2) By Source: Mammalian; Non-Mammalian
3) By Service: Manufacturing; Fill And Finish Operations; Analytical And QC (Quality Check) Studies; Packaging
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; Canada; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; biopharmaceutical contract manufacturing organization (CMO) indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
10 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market Segmentation
10.1 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
11 Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Regional and Country Analysis
11.1 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.1.1 Market Overview
12.1.2 Region Information
12.1.3 Market Information
12.1.4 Background Information
12.1.5 Government Initiatives
12.1.6 Regulations
12.1.7 Regulatory Bodies
12.1.8 Major Associations
12.1.9 Taxes Levied
12.1.10 Corporate Tax Structure
12.1.11 Investments
12.1.12 Major Companies
12.2 Asia Pacific Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.3 Asia Pacific Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia Pacific Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Biopharmaceutical Contract Manufacturing Organization (CMO) Market: Country Analysis
12.6 China Market
12.7 Summary
12.7.1 Market Overview
12.7.2 Country Information
12.7.3 Market Information
12.7.4 Background Information
12.7.5 Government Initiatives
12.7.6 Regulations
12.7.7 Regulatory Bodies
12.7.8 Major Associations
12.7.9 Taxes Levied
12.7.10 Corporate Tax Structure
12.7.11 Investments
12.7.12 Major Companies
12.8 China Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.9 China Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.10 China Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.11 India Market
12.12 India Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.13 India Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.14 India Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.15 Japan Market
12.16 Japan Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.19 Australia Market
12.20 Australia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.22 Australia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.30 South Korea Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.1.1 Market Overview
13.1.2 Region Information
13.1.3 Market Information
13.1.4 Background Information
13.1.5 Government Initiatives
13.1.6 Regulations
13.1.7 Regulatory Bodies
13.1.8 Major Associations
13.1.9 Taxes Levied
13.1.10 Corporate Tax Structure
13.1.11 Investments
13.1.12 Major Companies
13.2 Western Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market: Country Analysis
13.6 UK Market
13.7 UK Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.8 UK Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.10 Germany Market
13.11 Germany Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.12 Germany Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.14 France Market
13.15 France Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.16 France Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.17 France Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.18 Italy Market
13.19 Italy Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.20 Italy Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.21 Italy Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.22 Spain Market
13.23 Spain Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.24 Spain Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.25 Spain Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.1.1 Market Overview
14.1.2 Region Information
14.1.3 Market Information
14.1.4 Background Information
14.1.5 Government Initiatives
14.1.6 Regulations
14.1.7 Regulatory Bodies
14.1.8 Major Associations
14.1.9 Taxes Levied
14.1.10 Corporate Tax Structure
14.1.11 Investments
14.1.12 Major Companies
14.2 Eastern Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market: Country Analysis
14.6 Russia Market
14.7 Russia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.8 Russia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15 North America Market
15.1 Summary
15.1.1 Market Overview
15.1.2 Region Information
15.1.3 Market Information
15.1.4 Background Information
15.1.5 Government Initiatives
15.1.6 Regulations
15.1.7 Regulatory Bodies
15.1.8 Major Associations
15.1.9 Taxes Levied
15.1.10 Corporate Tax Structure
15.1.11 Investments
15.1.12 Major Companies
15.2 North America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.3 North America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Biopharmaceutical Contract Manufacturing Organization (CMO) Market: Country Analysis
15.6 USA Market
15.7 Summary
15.7.1 Market Overview
15.7.2 Country Information
15.7.3 Market Information
15.7.4 Background Information
15.7.5 Government Initiatives
15.7.6 Regulations
15.7.7 Regulatory Bodies
15.7.8 Major Associations
15.7.9 Taxes Levied
15.7.10 Corporate Tax Structure
15.7.11 Investments
15.7.12 Major Companies
15.8 USA Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.9 USA Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.10 USA Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.11 Canada Market
15.12 Canada Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.14 Canada Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16 South America Market
16.1 Summary
16.1.1 Market Overview
16.1.2 Region Information
16.1.3 Market Information
16.1.4 Background Information
16.1.5 Government Initiatives
16.1.6 Regulations
16.1.7 Regulatory Bodies
16.1.8 Major Associations
16.1.9 Taxes Levied
16.1.10 Corporate Tax Structure
16.1.11 Investments
16.1.12 Major Companies
16.2 South America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.3 South America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Biopharmaceutical Contract Manufacturing Organization (CMO) Market: Country Analysis
16.6 Brazil Market
16.7 Brazil Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.8 Brazil Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.1.1 Market Overview
17.1.2 Region Information
17.1.3 Market Information
17.1.4 Background Information
17.1.5 Government Initiatives
17.1.6 Regulations
17.1.7 Regulatory Bodies
17.1.8 Major Associations
17.1.9 Taxes Levied
17.1.10 Corporate Tax Structure
17.1.11 Investments
17.1.12 Major Companies
17.2 Middle East Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market
18.1 Summary
18.1.1 Market Overview
18.1.2 Region Information
18.1.3 Market Information
18.1.4 Background Information
18.1.5 Government Initiatives
18.1.6 Regulations
18.1.7 Regulatory Bodies
18.1.8 Major Associations
18.1.9 Taxes Levied
18.1.10 Corporate Tax Structure
18.1.11 Investments
18.1.12 Major Companies
18.2 Africa Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18.3 Africa Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape And Company Profiles
19.1 Company Profiles
19.2 Catalent Inc
19.2.1 Company Overview
19.2.2 Products And Services
19.2.3 Business Strategy
19.2.4 Financial Overview
19.3 Cytiva
19.3.1 Company Overview
19.3.2 Products And Services
19.3.3 Business Strategy
19.3.4 Financial Overview
19.4 Rentschler Biopharma
19.4.1 Company Overview
19.4.2 Products And Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 Boehringer Ingelheim International GmbH
19.5.1 Company Overview
19.5.2 Products And Services
19.5.3 Financial Overview
19.6 AGC Biologics Inc
19.6.1 Company Overview
19.6.2 Products And Services
19.6.3 Business Strategy
19.6.4 Financial Overview
20 Competitive Benchmarking
21 Competitive Dashboard
22 Key Mergers And Acquisitions
22.1 Novo Nordisk Acquired Catalent
22.2 Advent International And Warburg Pincus Acquired Baxter’s Biopharma Solutions (BPS) Business
22.3 The Biofarma Group Acquired U.S. Pharma Lab
22.4 Wacker Chemie Acquired ADL BioPharma
22.5 Catalent Acquired Metrics Contract Services
22.6 Bora Pharmaceuticals Acquired Eden Biologics
22.7 AstraZeneca Acquired Alexion Pharmaceuticals
23 Opportunities And Strategies
23.1 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market In 2028 – Countries Offering Most New Opportunities
23.2 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market In 2028 – Segments Offering Most New Opportunities
23.3 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market In 2028 – Growth Strategies
23.3.1 Market Trend Based Strategies
23.3.2 Competitor Strategies
24 Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Conclusions And Recommendations